Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2022.0446
Abstract: Key Points Question Are there differences in the magnitude and durability of neutralizing antibody (nAb) responses against SARS-CoV-2 variants of concern (VOCs) according to the mRNA-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) vaccines? Findings In this comparative… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.23319
Abstract: To evaluate clinical features, bacterial characteristics, and risk factors for shock and mortality of immunocompromised patients with Escherichia coli bacteremia. read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Clinical Neuroradiology"
DOI: 10.1007/s00062-017-0629-1
Abstract: PurposeThe aim of this study was to describe radiological imaging findings of a complicated sinusitis, which should raise the suspicion of rhino-orbital-cerebral mucormycosis as being the underlying cause.MethodsIn this retrospective analysis, we describe the cases and… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Intensive Care Medicine"
DOI: 10.1007/s00134-017-4857-2
Abstract: Introduction Immunocompromised patients represent a growing proportion of critically ill patients [1]. These patients do not have the ability to respond normally to an infection due to an impaired or weakened immune system. This inability… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Intensive Care Medicine"
DOI: 10.1007/s00134-017-4947-1
Abstract: BackgroundIn immunocompromised patients with acute hypoxemic respiratory failure (ARF), initial management aims primarily to avoid invasive mechanical ventilation (IMV).MethodsTo assess the impact of initial management on IMV and mortality rates, we performed a multinational observational… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "European Radiology"
DOI: 10.1007/s00330-019-06235-3
Abstract: ObjectivesThe aims of this study were to compare the high-resolution computed tomography (HRCT) findings of pulmonary infections in immunocompromised patients and to assess the usefulness of HRCT in the differential diagnosis of these infections.MethodsA total… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Maxillofacial and Oral Surgery"
DOI: 10.1007/s12663-019-01201-4
Abstract: Objective To retrospectively study the cases diagnosed with osteomyelitis of jaw in AMC Dental Hospital. Study Design A total of 27 cases of osteomyelitis of jaw were analysed retrospectively from 2014 to 2018 at Department… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Chest"
DOI: 10.1016/j.chest.2018.06.018
Abstract: Characteristic Value Age, y 57.63 14.73 Male sex 306 (58.6) Hospitalization (IQR), d 11 (3; 25) Symptoms and signs Cough 300 (57.5) Dyspnea 124 (23.8) Sputum 118 (22.6) Fever 108 (20.7) Decrease in FEV1 %… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Chest"
DOI: 10.1016/j.chest.2020.06.051
Abstract: Abstract Diffuse alveolar hemorrhage (DAH) is a severe and potentially life-threatening disease manifestation. Besides autoimmune diseases such as anti-neutrophil cytoplasmatic antibody (ANCA) associated vasculitis and anti-glomerular basement membrane (anti-GBM) syndrome pulmonary viral infections are also… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "EClinicalMedicine"
DOI: 10.1016/j.eclinm.2021.101158
Abstract: Background Trials of the Pfizer-BioNTech BNT162b2 mRNA vaccine showed 95% efficacy in preventing symptomatic disease; however, the trials excluded immunocompromised patients (ICPs). We aim at analyzing antibody response in ICPs. Methods A prospective cohort study… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Medicine"
DOI: 10.1016/j.med.2018.04.011
Abstract: Recipients of the different types of transplantation are at high risk of infection. Nosocomial infections predominate in patients who have undergone haematopoietic stem cell transplantation during the early post-engraftment period (30-100 days after the infusion);… read more here.